Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 250Leukemia 186Leukemia, Myeloid, Acute 103Myelodysplastic Syndromes 78Lymphoma 73Burkitt Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 49Leukemia, Myeloid, Accelerated Phase 45Lymphoma, Non-Hodgkin 44Hodgkin Disease 41Lymphoma, Large B-Cell, Diffuse 40Leukemia, Myeloid, Chronic-Phase 39Graft vs Host Disease 39Congenital Abnormalities 39Myeloproliferative Disorders 38Blast Crisis 38Lymphoma, Follicular 37Leukemia, Myelomonocytic, Chronic 37Multiple Myeloma 35Leukemia, Biphenotypic, Acute 35Lymphoma, Mantle-Cell 34Lymphoma, Large-Cell, Immunoblastic 31Lymphoma, B-Cell, Marginal Zone 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Recurrence 29Primary Myelofibrosis 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Anemia, Refractory, with Excess of Blasts 24Neoplasms, Plasma Cell 23Hematologic Neoplasms 23

Interventions

Alemtuzumab 3Cyclophosphamide 2tocilizumab 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Melphalan 1Etoposide 1Dexamethasone 1Cytarabine 1Calcium Dobesilate 1Busulfan 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphohistiocytosis, Hemophagocytic × Methotrexate × Other hematologic neoplasm × Clear all
NCT02385110 2024-01-17

Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

M.D. Anderson Cancer Center

Phase 2 Completed
18 enrolled 10 charts
MyeloidOther hematologic neoplasm

Leukemia, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡